Skip to content

Clinical trials

Multiple Endocrine Neoplasia Type 1 trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Endocrine Neoplasia Type 1 Country / region: Canada Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20062
20071
20101
20111
20141
20153
20162
20173
20181
20193
20202
20211
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The Hospital for Sick Children6
Novartis Pharmaceuticals3
Laval University2
Amgen1
Astellas Pharma Inc1
Bayer1
Ciusss de L'Est de l'Île de Montréal1
Joan Bottorff1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
McGill University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Endocrine Neoplasia Type 125
Neoplasms3
Obesity3
Breast Neoplasms2
Cardiovascular Diseases2
Overweight2
Prostatic Neoplasms2
Breast Diseases1
Chronic Disease1
Coronary Disease1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.